1st Quarter - Report — DALRYMPLE & ASSOCIATES, LLC for SANOFI PASTEUR (2014)

Firm

DALRYMPLE & ASSOCIATES, LLC

Client

SANOFI PASTEUR

Income

$15,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Childhood, adult and biodefense vaccine issues

Foreign entity interest: 100% Sanofi Pasteur Worldwide, 2 Avenue Point, F-69367, Lyon, France

Lobbyist	Covered position, as disclosed
DONALD DALRYMPLE New	Principal

Contacted: SENATE; Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

Funding and appropriations for adult, childhood and biodefense vaccines and other medical countermeasures

Foreign entity interest: 100% Sanofi Pasteur Worldwide, 2 Avenue Point, F-69367, Lyon, France

Lobbyist	Covered position, as disclosed
DONALD DALRYMPLE New	Principal

Contacted: Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.